Finland· FI-REL-REL22006
Optimmune vet
A siklosporiini product containing ciclosporin, registered in Finland by Intervet International B.V.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ciclosporin is registered in 2 of 19 countries.
Countries holding a registration under ATC QS01XA18 (siklosporiini), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Ciclosporin · ATC QS01XA18
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Ciclosporin
- Manufacturer
- Intervet International B.V.
- Country
- Finland (FI)
- ATC code
- QS01XA18
- ATC class
- Siklosporiini
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciclosporin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCapimune 100mg capsulesViatris UK Healthcare Ltd
- CzechiaCICLOSPORIN MYLANMylan Ireland Limited, Dublin
- United StatesCEQUASun Pharmaceutical Industries, Inc.
- SwedenCequa 0,9 mg/ml Ögondroppar, lösning i endosbehållareSun Pharmaceutical Industries Europe B.V.
- BelgiumCiclosporin Sandoz 10 mgSandoz
- CanadaATOPICAELANCO CANADA LIMITED
- PolandCyclaidAurovitas Pharma Polska Sp. z o.o.
- NetherlandsCequa 0,9 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikSun Pharmaceutical Industries Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Cequa®, Neoimmun
- Belgium · Neoral-Sandimmun, Sandimmun
- Bulgaria · Сандимун Неорал
- Cyprus · Sandimmun Neoral
- Czechia · Ciclosporin Viatris, Equoral
- Germany · Cequa, Cicloral
- Denmark · Ciqorin, Menelri
- Estonia · Equoral, Sandimmun Neoral
- Spain · Cequa, Ciqorin
- France · Cequa, Ciclograft
- United Kingdom (Northern Ireland) · Capimune, Capsorin
- Greece · Imunofar, Sandimmun
- Croatia · Ciklosporin Alkaloid, Equoral
- Hungary · Sandimmun, Sandimmun Neoral
- Ireland · Deximune, Neoral
- Iceland · Ciqorin, Ikervis
- Italy · Cequa, Ciqorin
- Liechtenstein · Ikervis, Verkazia
- Lithuania · Equoral, Sandimmun Neoral
- Luxembourg · Neoral-Sandimmun, Sandimmun
- Latvia · Sandimmun Neoral
- Malta · Deximune, Sandimmun Neoral
- Netherlands · Cequa, Ciclosporin Teva
- Norway · Cequa, Ikervis
- Poland · Cyclaid, Equoral
- Portugal · Ciclosporina Flica Germed Farmacêutica, Ciclosporina Generis
- Romania · Cequa, Sandimmun Neoral
- Sweden · Cequa, Ciklosporin Ivax
- Slovenia · Sandimmun, Sandimmun Neoral
- Slovakia · Ciclosporin Viatris, Equoral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d2c0b38-87a5-4b2e-b8df-82c8887e3e26 GET /v1/drugs/4d2c0b38-87a5-4b2e-b8df-82c8887e3e26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmävoide",
"route": "Silmän pinnalle",
"ddd_unit": null,
"strength": "2 mg/g",
"atc_label": "Siklosporiini",
"ma_number": "19779",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL22006",
"authorised_at": "2009-12-14"
}See everything about ciclosporin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.